Jacob Gadwa

6PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 08, 2025
Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment.

Jacob Gadwa, Justin Yu, Miles Piper

|Aug 02, 2024
Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HNSCC.

Khalid N M Abdelazeem, Diemmy Nguyen, Sophia Corbo

|Feb 16, 2024
PPARα Agonism Enhances Immune Response to Radiotherapy While Dietary Oleic Acid Results in Counteraction.

Richard Blake Ross, Jacob Gadwa, Justin Yu

|Apr 22, 2021
Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.

Michael W Knitz, Thomas E Bickett, Laurel B Darragh

|Apr 01, 2021
Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer.

Jacob Gadwa, Thomas E Bickett, Laurel B Darragh

Pageof 1